180 Epizód

  1. PARP Inhibitors in the Management of Ovarian Cancer Rapid Recommendation Update

    Közzétéve: 2022. 10. 03.

  2. Secondary Prevention of Cervical Cancer Resource-Stratified Guideline Update

    Közzétéve: 2022. 09. 26.

  3. Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Rapid Recommendation Update

    Közzétéve: 2022. 09. 21.

  4. Integrative Medicine for Pain Management in Oncology: SIO-ASCO Guideline

    Közzétéve: 2022. 09. 19.

  5. Chemotherapy and Targeted Therapy for HER2-Negative Metastatic Breast Cancer that is Either Endocrine-Pretreated or Hormone Receptor–Negative: ASCO Guideline Rapid Recommendation Update

    Közzétéve: 2022. 08. 04.

  6. Therapy for Stage IV Non-Small Cell Lung Cancer without Driver Alterations: ASCO Living Guideline (Part 1)

    Közzétéve: 2022. 07. 11.

  7. Therapy for Stage IV Non-Small Cell Lung Cancer with Driver Alterations: ASCO Living Guideline (Part 2)

    Közzétéve: 2022. 07. 11.

  8. Biomarkers for Systemic Therapy in Metastatic Breast Cancer Guideline Update

    Közzétéve: 2022. 06. 27.

  9. Management of Metastatic Clear Cell Renal Cell Carcinoma Guideline

    Közzétéve: 2022. 06. 21.

  10. Systemic Therapy for Melanoma Rapid Recommendation Update

    Közzétéve: 2022. 06. 03.

  11. Management of Advanced HER2-Positive Breast Cancer and Brain Metastases Guideline Update

    Közzétéve: 2022. 05. 31.

  12. Systemic Therapy for Advanced HER2-Positive Breast Cancer Guideline Update

    Közzétéve: 2022. 05. 31.

  13. Exercise, Diet, and Weight Management During Cancer Treatment Guideline

    Közzétéve: 2022. 05. 16.

  14. Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline

    Közzétéve: 2022. 05. 13.

  15. Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer Guideline Update

    Közzétéve: 2022. 04. 19.

  16. Use of Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of High-risk, Early-stage Triple Negative Breast Cancer Rapid Recommendation Update

    Közzétéve: 2022. 04. 13.

  17. Management and Care of Patients with Invasive Cervical Cancer: Resource-Stratified Guideline Rapid Recommendation Update

    Közzétéve: 2022. 03. 07.

  18. Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update

    Közzétéve: 2022. 02. 24.

  19. Somatic Genomic Testing in Patients with Metastatic or Advanced Cancer Provisional Clinical Opinion

    Közzétéve: 2022. 02. 17.

  20. Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected NSCLC Guideline Rapid Recommendation Update

    Közzétéve: 2022. 02. 14.

4 / 9

Explore pivotal recommendations from the latest evidence-based clinical practice guidance with ASCO Guidelines. Join us to discover essential insights and navigate the ever-evolving landscape of cancer research and treatment.

Visit the podcast's native language site